Form 4: Adverum Biotechnologies Director Leonard Buys Additional Shares

Director Braden Michael Leonard reports purchasing additional shares of Adverum Biotechnologies, Inc. (ADVM) on April 22nd and 23rd, 2025.

Summary

• Braden Michael Leonard, a director of Adverum Biotechnologies, Inc., reported acquiring additional shares of the company's common stock.
• On April 22, 2025, Leonard purchased 300,000 shares at $3 per share.
• These shares are held indirectly through BML Investment Partners, L.P.
• On April 23, 2025, Leonard purchased 50,000 shares at a weighted average price of $2.979 per share.
• These shares are held directly.
• Following these transactions, Leonard directly owns 191,800 shares and indirectly owns 3,057,526 shares through BML Investment Partners, L.P.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed as a positive sign, but the document itself is simply a report of the transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as an indicator of management's sentiment towards the company's prospects. It can be a positive signal, but should be considered alongside other factors.

Key Dates

Keywords

Adverum Biotechnologies, ADVM, Insider Trading, Form 4, Stock Purchase, Braden Michael Leonard, Director